tiprankstipranks
Ansell (CH:PD1A)
:PD1A
Switzerland Market
PD1A
Ansell
RESEARCH TOOLSreports

Ansell (PD1A) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

PD1A Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
2 Buy
4 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Ansell
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PD1A Stock 12 Month Forecast

Average Price Target

―
Based on 6 Wall Street analysts offering 12 month price targets for Ansell in the last 3 months. The average price target is CHF19.50 with a high forecast of CHF21.64 and a low forecast of CHF16.60. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF21.64Average Price TargetCHF19.50Lowest Price TargetCHF16.60
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Macquarie Analyst forecast on CH:PD1A
Unknown Analyst
Macquarie
Not Ranked
Macquarie
CHF19.99
Hold
―
Reiterated
07/31/26
Macquarie Keeps Their Hold Rating on Ansell (ANSLF)
Jefferies Analyst forecast on CH:PD1A
Vanessa Thomson
Jefferies
Jefferies
CHF21.64
Buy
―
Reiterated
07/28/26
Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)
RBC Capital Analyst forecast on CH:PD1A
Craig Wong-Pan
RBC Capital
RBC Capital
CHF20.39
Buy
―
Reiterated
07/16/26
Ansell (ANSLF) Gets a Buy from RBC Capital
UBS Analyst forecast on CH:PD1A
David Low
UBS
UBS
CHF19.4
Hold
―
Reiterated
07/06/26
Analysts Offer Insights on Healthcare Companies: MiMedx Group (NASDAQ: MDXG) and Ansell (Other OTC: ANSLF)
Citi Analyst forecast on CH:PD1A
Laura Sutcliffe
Citi
Citi
CHF18.98
Hold
―
Reiterated
07/06/26
Citi Remains a Hold on Ansell (ANSLF)
Morgan Stanley Analyst forecast on CH:PD1A
David Bailey
Morgan Stanley
Morgan Stanley
CHF19.49→CHF16.6
Hold
―
Reiterated
05/06/26
Morgan Stanley Reaffirms Their Hold Rating on Ansell (ANSLF)
Ord Minnett Analyst forecast on CH:PD1A
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
CHF19.71
Buy
―
Upgraded
04/13/26
Positive Report for Ansell (ANSLF) from Ord Minnett
Goldman Sachs Analyst forecast on CH:PD1A
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
CHF18.01
Hold
―
Initiated
04/07/26
Ansell Limited: Efficiency Gains Offset by Margin Pressures and Unclear Growth Trajectory Support Hold Rating
Morgans Analyst forecast on CH:PD1A
Derek Jellinek
Morgans
Morgans
CHF19.96
Hold
―
Reiterated
02/16/26
Ansell (ANSLF) Gets a Hold from Morgans
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Macquarie Analyst forecast on CH:PD1A
Unknown Analyst
Macquarie
Not Ranked
Macquarie
CHF19.99
Hold
―
Reiterated
07/31/26
Macquarie Keeps Their Hold Rating on Ansell (ANSLF)
Jefferies Analyst forecast on CH:PD1A
Vanessa Thomson
Jefferies
Jefferies
CHF21.64
Buy
―
Reiterated
07/28/26
Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)
RBC Capital Analyst forecast on CH:PD1A
Craig Wong-Pan
RBC Capital
RBC Capital
CHF20.39
Buy
―
Reiterated
07/16/26
Ansell (ANSLF) Gets a Buy from RBC Capital
UBS Analyst forecast on CH:PD1A
David Low
UBS
UBS
CHF19.4
Hold
―
Reiterated
07/06/26
Analysts Offer Insights on Healthcare Companies: MiMedx Group (NASDAQ: MDXG) and Ansell (Other OTC: ANSLF)
Citi Analyst forecast on CH:PD1A
Laura Sutcliffe
Citi
Citi
CHF18.98
Hold
―
Reiterated
07/06/26
Citi Remains a Hold on Ansell (ANSLF)
Morgan Stanley Analyst forecast on CH:PD1A
David Bailey
Morgan Stanley
Morgan Stanley
CHF19.49→CHF16.6
Hold
―
Reiterated
05/06/26
Morgan Stanley Reaffirms Their Hold Rating on Ansell (ANSLF)
Ord Minnett Analyst forecast on CH:PD1A
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
CHF19.71
Buy
―
Upgraded
04/13/26
Positive Report for Ansell (ANSLF) from Ord Minnett
Goldman Sachs Analyst forecast on CH:PD1A
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
CHF18.01
Hold
―
Initiated
04/07/26
Ansell Limited: Efficiency Gains Offset by Margin Pressures and Unclear Growth Trajectory Support Hold Rating
Morgans Analyst forecast on CH:PD1A
Derek Jellinek
Morgans
Morgans
CHF19.96
Hold
―
Reiterated
02/16/26
Ansell (ANSLF) Gets a Hold from Morgans
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ansell

3 Months
Vanessa ThomsonJefferies
Success Rate
6/8 ratings generated profit
75%
Average Return
+10.80%
Copying Vanessa Thomson's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +10.80% per trade.
1 Year
Vanessa ThomsonJefferies
Success Rate
6/8 ratings generated profit
75%
Average Return
+22.32%
Copying Vanessa Thomson's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +22.32% per trade.
2 Years
Vanessa ThomsonJefferies
Success Rate
6/8 ratings generated profit
75%
Average Return
+13.28%
Copying Vanessa Thomson's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +13.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PD1A Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
3
1
1
2
2
Hold
7
3
2
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
4
3
6
5
In the current month, PD1A has received 2 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. PD1A average Analyst price target in the past 3 months is 19.50.
Each month's total comprises the sum of three months' worth of ratings.

PD1A Financial Forecast

PD1A Earnings Forecast

Next quarter’s earnings estimate for PD1A is CHF0.61 with a range of CHF0.59 to CHF0.64. The previous quarter’s EPS was CHF0.54. PD1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.
Next quarter’s earnings estimate for PD1A is CHF0.61 with a range of CHF0.59 to CHF0.64. The previous quarter’s EPS was CHF0.54. PD1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.

PD1A Sales Forecast

Next quarter’s sales forecast for PD1A is CHF835.68M with a range of CHF817.81M to CHF850.36M. The previous quarter’s sales results were CHF884.80M. PD1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.23% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.
Next quarter’s sales forecast for PD1A is CHF835.68M with a range of CHF817.81M to CHF850.36M. The previous quarter’s sales results were CHF884.80M. PD1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.23% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.

PD1A Stock Forecast FAQ

What is CH:PD1A’s average 12-month price target, according to analysts?
Based on analyst ratings, Ansell’s 12-month average price target is 19.50.
    What is CH:PD1A’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:PD1A, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Ansell a Buy, Sell or Hold?
        Ansell has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Ansell’s share price target?
          The average share price target for Ansell is 19.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF21.64 ,and the lowest forecast is CHF16.60. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Ansell?
            Ansell’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Ansell?
              To buy shares of CH:PD1A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.